Therabel is a European pharmaceutical company with a rich heritage dating back to 1945. The company has expanded internationally through acquisitions and organic growth. Its product portfolio is primarily developed through collaborations with other pharmaceutical companies, ensuring a high level of commitment and focus. Therabel aims to provide safe and effective therapeutic solutions to European healthcare professionals and patients through its expertise in market access and commercialization. The company operates within the Biotechnology and Pharmaceutical industries, with a focus on developing and making partner products available. Currently, there is no publicly available information about the company's headquarters, last investment, or investors. Therabel's commitment to expanding its product portfolio and market access presents opportunities for potential investors seeking exposure to the pharmaceutical industry.
There is no investment information
No recent news or press coverage available for Therabel.
We care about your data, and we'd love to use cookies make your experience better.